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ABSTRACT 
Postpartum cardiomyopathy (PPCM) is dilated 
cardiomyopathy seen in the postpartum period 
in women who no prior history of cardiac 
diseases. In this case study, coronary 
angiography was used to determine the 
etiology of the cardiomyopathy after the 
decompensated heart failure had regressed. A 
congenital single coronary artery anomaly was 
detected by coronary angiography. In this 
case, PPCM can mimic pneumonia, thus 
making diagnosis difficult. When there is no 
response to antibiotic therapy, the obstetrician 
must consider cardiac disease and appropriate 
consultation should be obtained as soon as 
possible. To the best of our knowledge, single 
coronary artery anomalies coexisting with 
PPCM has only been documented in one other 
case in the literature. An association of single 
coronary artery anomalies with PPCM may be 
random, or, alternative, might contribute to the 
composition of the PPCM. 
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INTRODUCTION 
Peripartum cardiomyopathy is 
idiopathic heart failure occurring in the 
absence of any determinable heart 
disease during the last month of 
pregnancy or the first 5 months 
postpartum.1 It was first described by 
Demakis and colleagues in 1971. Its 
prevalence is higher in developing 
countries, e.g Nigeria, Haiti and Africa. 
The exact cause of postpartum 
cardiomyopathy (PPCM) is unknown, 
but various viral infections and 
autoantibodies have been implicated in 
the pathogenesis of this disease.2 In 
addition, advanced maternal age, 
multiparity, African descent, twin 
pregnancy, pregnancy-induced 
hypertension and long-time 
miscarriage are also found to be 
related to PPCM, but no casual 
association has been shown.3 
Proposed etiologies for PPCM include 
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inflammation, genetic mechanisms, 
abnormal responses to the physiologic 
stress of pregnancy, autoimmune 
factors, viral myocarditis, nutritional 
deficiencies, and prolonged tocolysis. 
Thus, the exact cause of PPCM is 
unknown and the pathogenesis is 
probably multi-factorial.   
Coronary artery anomalies are 
observed in 0.3-1.3% of patients 
undergoing diagnostic coronary 
angiography, in approximately 1% of 
routine autopsy examinations, and in 
4-15% of young people who 
experience sudden death. In the 
general population, the incidence of a 
single coronary artery is approximately 
0.024%.4  
Coronary artery anomalies are 
frequently associated with other major 
congenital anomalies like tetralogy of 
Fallot and transposition of great artery 
anomalies. It is strongly associated 
with sudden death, myocardial 
ischemia, congestive heart failure and 
endocarditis. To the best of our 
knowledge, the coexistence of single 
coronary artery anomalies with PPCM 
has only been reported in one case in 
the literature. We report a rare case of 
PPCM with a single coronary artery 
anomalies.  
CASE REPORT 
A forty nine-year-old female patient 
was admitted to the cardiology clinic 
with complaints of dyspnea, coughing 
and inability to lie on her back. She 
had no chronic diseases, except 
Hashimoto’s thyroiditis. She had used 
levothyroxine therapy for two years, 
and she did not smoke. She had given 
birth to her ninth baby by normal 
vaginal delivery one month previously 
and the labor was unproblematic. Her 
complaints began two weeks after 
delivery when she was admitted to the 
gynecology and obstetrics clinic with 
similar complaints. She was diagnosed 
with pneumonia and started a course 
of antibiotic therapy. However, she did 
not respond to therapy. The patient 
was referred to the cardiology clinic 
given her dyspnea increased and 
orthopnea and pretibial edema 
developed. Upon her physical 
examination, dyspnea, orthopnea and 
generalized pretibial edema were 
observed, her heart rate was 100 bpm, 
and blood pressure was 130/80 
mmHg. In the cardiac auscultation, 
heart sounds were rhythmic, 
tachycardic, S1+, S2+, S3+ and there 
was a 2/6 pansystolic murmur at the 
apex. In the lung auscultation, bilateral 
respiratory sounds were equal; 
however, she had generalized 
crepitant rales up to the middle zone. 
The anteroposterior radiograph of the 
chest showed increased cardiothoracic 
ratio and hyperdense areas in bilateral 
perihilar areas consistent with 
pulmonary venous congestion (Image 
1).  
 
Image 1. AP chest x-ray, CTR>0.50. 
Hyperdense areas in bilateral 
perihilar region and bilateral 
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perihilar fullness. 
The ECG showed normal sinus rhythm 
and there was an anteroseptal QS 
wave. Laboratory tests were normal. In 
the echocardiography, there was an 
ejection fraction of 0.35, the left 
ventricle was dilated, the left ventricle 
diastolic diameter was 60 mm and 
there was global hypokinesia, 
particularly in the inferior, inferoapical 
and septobasal areas and the lateral 
wall (Image 2).  
 
Image 2.   
Postpartum cardiomyopathy.   
Left ventricle diastolic diameter was 
60 mm. 
 
The aorta and bilateral atria were 
enlarged. Moderate mitral valve 
insufficiency and mild tricuspid and 
aortic valve insufficiency were detected 
by color and conventional Doppler 
examination. The patient, who had 
experienced no previous cardiac 
disease, was diagnosed with PPCM. 
After the decompensated heat failure 
had regressed, the patient underwent 
coronary angiography in order to 
determine the etiology of the 
cardiomyopathy. A congenital single 
coronary artery anomaly originating 
from the right coronary cusp and 
branching to the right and left coronary 
arteries was detected by coronary 
angiography (Image 3). No occlusion 
was detected in the coronary arteries. 
In the ventriculography, generalized 
hypokinesia was detected in the left 
ventricle and the ejection fraction was 
found to be 38%. Ischemic heart 
disease was excluded. 
 
Image 3: Coronary angiography 
showing the anomalous origin of 
the left main (LM) coronary artery 
from proximal right coronary artery 
(RCA) with subsequent retroaortic 
(dorsal [type D]) course to the left 
side.  
In light of these data, a course of 80 
mg parenteral furosemide, 5 mg oral 
perindopril, and 25 mg oral 
spirinolactone, digoxin and a salt-free 
diet was started. Fluid restriction was 
also recommended. Hemodynamic 
instability and systolic dysfunction were 
not observed, so the patient did not 
require a ventricular assist device, 
inotropic agents or cardiac 
transplantation. Dyspnea regressed 
and lung rales as determined by 
auscultation decreased about two 
weeks after the drug therapy. 
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Therefore, 12.5 mg carvedilol was 
added to the medical therapy. Fluid 
retention declined, the pretibial edema 
was resolved, and shortness of breath 
improved (clinical NYHA functional 
class improved from class III to class 
II). The effort capacity of the patient 
was increased and the patient was 
discharged with oral diuretic treatment. 
The patient was reevaluated by 
physical examination and 
echocardiography in the 3rd and 6th 
month follow ups. In the follow up 
examination, the shortness of breath 
had regressed (NYHA I), the ejection 
fraction was 45% in the third month 
and 50% in the sixth month as 
determined by echocardiography, and 
the size of the left ventricle had 
decreased. 
DISCUSSION 
PPCM is dilated cardiomyopathy 
emerging in the postpartum period in 
women who have had no previous 
cardiac diseases. It develops in the last 
prenatal month or within five months 
postpartum. It is defined as a disease 
with unexplained left ventricle systolic 
dysfunction and is diagnosed by 
echocardiography.5 
In women who have developed PPCM, 
heart failure is usually accompanied by 
explicit fluid retention and less 
frequently embolic stroke, and 
arrhythmia may develop. Cases with 
poor prognosis tend to develop within 
the first few days postpartum. Heart 
failure may be severe; inotropic agents 
and ventricular support devices may be 
required. In these cases mortality 
varies between 3% and 60% in the 
acute and subacute phases. PPCM 
incidence is one in 1,300-15,000 live 
births. This wide range in incidence 
and mortality may be explained by 
geographic differences, differences in 
diagnostic criteria and widespread use 
of echocardiography. Congestive heart 
failure, arrhythmia and thromboembolic 
events are responsible for mortality. 
In our case, PPCM was considered in 
the differential diagnosis as heart 
failure symptoms accompanied by fluid 
retention developed two weeks after 
delivery. 75% of patients are 
diagnosed in the first month 
postpartum and 40% are diagnosed 
within the first week.6 It is frequently 
seen in women 30 years and older but 
also in women of all age groups. 
Prognosis is related to the 
improvement of left ventricle functions, 
and ventricle functions return to normal 
within the first six months in 30% of 
patients and 50% recover fully. In our 
patient, hemodynamic instability and 
systolic dysfunction were not observed, 
so the patient did not require a 
ventricular assist device, inotropic 
agents or cardiac transplantation. 
Dyspnea regressed and lung rales 
decreased about two weeks after 
initiation of drug therapy.  Fluid 
retention declined, which resolved the 
pretibial edema and improved 
shortness of breath (clinical NYHA 
functional regressed from class III to 
class II). In the follow-up examination, 
the shortness of breath had regressed 
(NYHA I), the ejection fraction was 
45% in the third month and 50% in the 
sixth month and the size of the left 
ventricle had decreased. Both clinical 
and echocardiographic findings had 
resolved at the end of the sixth 
months.  
Although its etiology is not fully known, 
many risk factors are thought to play a 
role in PPCM, including advanced 
maternal age, grand multiparity, 
preeclampsia, long-standing tocolytic 
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therapy, black ethnicity, twin 
pregnancy and also viral infections, 
autoimmunity and selenium 
deficiency.7 Our case was a woman of 
advanced age who had not had any 
previous cardiac diseases and who 
was admitted with symptoms of heart 
failure. Grand multiparity and 
advanced age may have played a role 
in the development of PPCM in this 
case.  
In the pathophysiological development 
of PPCM, inflammatory agents (TNF-α, 
interferon-γ, interleukin-6, C-reactive 
protein), myocarditis, oxidative stress, 
fetal chimerism and genetic 
associations play an important role. 
With regards to the causal role of fetal 
chimerism, during pregnancy fetal cells 
escape into the maternal circulation but 
are normally destroyed by the maternal 
immune system. When the maternal 
immune system is weakened, chimeric 
cells invade and settle in the maternal 
heart. Maternal antibodies directly 
attached to the chimeric cells result in 
dilated cardiomyopathy. Consistent 
with this proposed mechanism, high 
titers of antibodies against the cardiac 
myosin cells have not been identified in 
healthy pregnant women or idiopathic 
dilated cardiomyopathy. Also, there is 
a strong relationship between high 
titers of antibodies and multiple and 
subsequent pregnancies.3 In our case, 
the patient had given birth to her ninth 
baby, thereby supporting the 
relationship with subsequent 
pregnancies. In addition, our patient 
had Hashimoto’s thyroiditis, an 
autoimmune condition. In our opinion, 
there might be a relationship between 
autoimmune antibodies and PPCM.  
Even after full recovery of left 
ventricular function, subsequent 
pregnancies carry a risk of relapse of 
PPCM. A study in Haiti followed 99 
patients, 15 of whom became pregnant 
again. Eight of the women who 
became pregnant again experienced 
worsening heart failure and long-term 
systolic dysfunction.8  We believe that 
patients with PPCM need close follow-
up due to the risk of recurrence in 
subsequent pregnancy.  
Patients with PPCM have the classical 
symptoms of cardiomyopathy: abruptly 
deteriorating dyspnea, orthopnea, 
coughing and tachycardia. Making a 
diagnosis may be difficult as these 
symptoms may also be seen in 
pulmonary thromboembolism, 
pneumonia, amniotic fluid embolism 
and asthma in pregnancy. Our case 
had dyspnea and coughing and was 
first diagnosed as pneumonia by the 
gynecology and obstetrics clinic. A 
course of antibiotics was started and 
she was referred to the cardiology 
clinic as no response to therapy could 
be obtained and the symptoms 
deteriorated. Thus, PPCM should 
certainly be considered in cases that 
have newly developing similar 
symptoms in the postpartum period. A 
cardiological evaluation should be 
made in order to make a diagnosis. 
Diagnosis is made upon 
echocardiography. Diagnosis may be 
made by showing that the ejection 
fraction is below 45%, systolic 
dysfunction and/or fractional 
shortening is below 30%, and/or 
diastolic diameter is above 2.7 cm/m2. 
In our case, the diastolic diameter was 
seen to increase (60 mm) (Image 2) 
and systolic functions globally 
decreased as seen by 
echocardiography and 
ventriculography. The disease has no 
specific treatment. Symptomatic 
treatment methods include fluid and 
sodium restriction, inotropic and 
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respiratory support and medical 
treatment for heart failure (ACE 
inhibitors, beta-blockers and 
diuretics).9 In our patient, we used both 
medical treatment methods, including 
beta-blockers, diuretics and digoxin 
and also symptomatic treatment 
methods of fluid and sodium restriction. 
Hemodynamic instability and systolic 
dysfunction were not observed so the 
patient did not require a ventricular 
assist device, inotropic agents 
(dopamine, dobutamine) or cardiac 
transplantation. 
Single coronary artery anomalies are 
usually asymptomatic but according to 
the severity of the atherosclerosis, 
myocardial ischemia, syncope and 
sudden death may also occur.   
When we searched for single coronary 
artery anomalies and PPCM in 
PubMed, we found only one case 
report. This was an anomalous origin 
of the left main coronary artery from 
the pulmonary trunk masquerading as 
peripartum cardiomyopathy. Daniels C. 
et al, presented a 16-year-old girl who 
was diagnosed with peripartum 
cardiomyopathy with congestive heart 
failure. Coronary angiography showed 
anomalous origin of the left main 
coronary artery from the pulmonary 
trunk.10  
Right and left coronary arteries 
normally originate from ostia which are 
normally located in the Valsalva 
sinuses of the aorta. In our case, the 
left coronary artery was seen to have 
originated from the right sinus Valsalva 
together with the right coronary artery 
from a single sinus. The patient was 
followed up with medical therapy as 
the course of the left coronary artery 
was normal. Most coronary artery 
anomaly cases do not show symptoms 
and they are usually detected during 
coronary angiography or incidentally 
during autopsies.10 Despite the 
absence of significant hemodynamic 
impairments in most coronary artery 
anomaly cases, there are also the 
cases which have resulted in 
myocardial ischemia and sudden 
death.11 Our case is interesting due to 
the coexistence of PPCM and single 
coronary artery anomaly. 
An association of single coronary 
artery anomalies with PPCM may be 
random or it might contribute to the 
composition of the PPCM. During 
coronary angiography performed to 
determine the etiology of the PPCM, 
single coronary artery anomalies 
should be kept in mind. As in this case, 
PPCM can mimic pneumonia and this 
situation makes the diagnosis difficult. 
When there is no response to 
antibiotics, the obstetrician must 
suspect cardiac disease and 
cardiological consultation should be 
done as soon as possible.  
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